Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinoma
SourceCancer Immunology Immunotherapy, 68, 2, (2019), pp. 319-329
Article / Letter to editor
Display more detailsDisplay less details
Cancer Immunology Immunotherapy
SubjectAll institutes and research themes of the Radboud University Medical Center; Radboudumc 9: Rare cancers RIHS: Radboud Institute for Health Sciences
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.